GeneDx Holdings Corp.

WGSSEC EDGAR

Services-Health Services(DE)CIK: 1818331

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$202.6M	$202.6M	$234.7M	$179.3M	$196.2M
Cost of Goods and Services Sold	$112.6M	$112.6M	$261.4M	$175.3M	$113.4M
Gross Profit	$90.0M	$90.0M	-$26.8M	$4.0M	$82.8M
Research and Development Expense	$58.3M	$58.3M	$86.2M	$72.7M	$34.9M
Operating Income (Loss)	-$180.6M	-$180.6M	-$667.7M	-$242.0M	-$30.4M
Interest Expense	—	—	—	$2.5M	$783.0K
Nonoperating Income (Expense)	$3.9M	$3.9M	$69.6M	$654.0K

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$419.4M	$418.8M	$490.9M	$554.1M	$251.6M
Assets, Current	$198.0M	$182.3M	$212.6M	$483.5M	$174.1M
Cash and Cash Equivalents, at Carrying Value	$85.2M	$99.7M	$123.9M	$108.1M	$108.1M
Accounts Receivable, after Allowance for Credit Loss, Current	$37.6M	—	—	$26.5M	$32.0M
Inventory, Net	$10.7M	$8.8M	$13.7M	$33.5M	$25.0M
Liabilities	$174.1M	$190.7M	$237.2M	$166.0M	$247.3M
Liabilities, Current	$54.8M	$58.8M	$144.3M	$101.3M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$180.1M	-$180.1M	-$319.2M	-$93.1M	-$18.7M
Net Cash Provided by (Used in) Investing Activities	-$43.7M	-$43.7M	-$141.3M	-$32.0M	-$15.5M
Net Cash Provided by (Used in) Financing Activities	$186.2M	$186.2M	$197.3M	$129.1M	$148.0M
Payments to Acquire Property, Plant, and Equipment	$5.3M	$5.3M	$7.2M	$24.1M	$11.9M

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)